2012 | || Engaging Key Opinion Leaders (KOLs) - Identifying

Document Sample
2012 | || Engaging Key Opinion Leaders (KOLs) - Identifying Powered By Docstoc
					                  Pharmaceutical & Healthcare announces, The Latest market research report is available in
its vast collection:

Engaging Key Opinion Leaders (KOLs) - Identifying and
Leveraging New KOL Groups to Drive Medical Marketing

You can also request for sample page of above mention reports on

GBI Research, the leading business intelligence provider, has released its latest
research, “Engaging Key Opinion Leaders (KOLs) - Identifying and Leveraging New
KOL Groups to Drive Medical Marketing Strategy”. This report examines the roles of
Key Opinion Leaders (KOLs) within the pharmaceutical industry now and in the
future. It looks at the roles traditionally held by KOLs. It describes the consequences
of the changing healthcare environment on how the industry identifies and works
with new groups of key opinion leaders, examining three areas of particular
importance for KOL management within the pharmaceutical industry today. Firstly,
the report will investigate the emerging trend to externalize research and to
establish productive relationships with academic laboratories and principal


Detailed analysis of the changes in the industry and healthcare environment that are
causing new groups of KOLs to emerge
Exploration of the influence of academic scientists on industry R&D as companies
look to externalize more of their research
                  Pharmaceutical & Healthcare
Detailed insights into the changing nature of the relationship of the industry with
healthcare professionals, including details of the current compliance environment
Examination of the role of patients in driving drug development within the industry
Study of the growing importance of online social networks in each of these areas
Investigation of how to identify and build successful relationships with these
emerging groups of KOLs

Reasons to Buy

Identify key groups that are considered influential for the future of the industry.
Develop strategies and priorities for engaging with these new groups of KOLs

Table of contents:

1.1 List of Tables
1.2 List of Figures
2 Executive Summary
2.1 New Roles for Key Opinion Leaders are Emerging
2.2 Effective Relationships with Experts in Academia are Key to Externalized
2.3 Company Policies are Changing to Reflect the New Compliance Environment
2.4 Patients Perspectives are Important
3 Introduction
3.1 Key Opinion Leaders: A History
3.2 Established KOL Roles in Drug Discovery, Development and Marketing
3.3 The Changing Environment for the Pharmaceutical Industry
3.3.1 Market Access: Reimbursement Authorities
3.3.2 Market Access: Purchasing
3.3.3 Generic and Specialty Medicines
3.3.4 Emerging Markets
3.3.5 Big Data: the Changing Environment for Science and Medicine
3.3.6 Emerging Business Models

List of Figures

List of Tables are also include.
                 Pharmaceutical & Healthcare

For more Latest Reports Please follow The links:

Peripheral Vascular Devices Market to 2018 - Increasing Demand for Minimally
Invasive Endovascular Procedures Presents Growth Opportunities for

Ultrabooks Market to 2016 - Financial and Technological Support from Intel
Corporation Coupled with Demand from Business Users Segment Will Drive Growth

Search More Reports Related to This Category :

Biomarkers in Drug Discovery - Earlier Usage of Biomarkers in Optimization Stage
to Reduce Drug Attrition Rate Significantly

Innovation in Drug Delivery - Broad-based Proprietary Technology Platforms to
Address Delivery Efficiency and Improve Patient Compliance

Epigenetics R&D Pipeline - Histone Deacetylases (HDACs) Offer the Most Promising
Targets and Outnumber Other Classes of Epigenetic Targets

Multi-Targeted Therapies - New Wave of Combination Therapies in Late Stage
Development for Lung Cancer Offer Promise
                Pharmaceutical & Healthcare

For More details Plz do contact :

Aarkstore Enterprise




Shared By: